Arquer Diagnostics is a UK-based company committed to manufacturing
and marketing innovative, non-invasive cancer tests for diagnosis
and monitoring.
Its first product, the pioneering ADXBLADDER, is a quick and
accurate way of diagnosing and monitoring bladder cancer, harnessing patented
technology to detect or rule out the presence of a cancer biomarker in the urine.


Results you can have confidence in.



  • Simplifies the diagnostic process
  • An easy-to-use ELISA (Enzyme-Linked Immunosorbent Assay)
  • Can be performed on a full void of urine as small as 10 mL


  • Sample collection is quick, easy and non-invasive
  • Uses established ELISA technology to deliver a rapid result. The ELISA can be run in as little as 2.5 hours


  • Clinical studies demonstrate a combined 95% sensitivity in high-risk tumours such as Clinical studies demonstrate a 95% sensitivity in high-grade tumours
  • Has a breakthrough NPV of 97%, allowing clinicians to correctly identify cancer-negative patients with confidence and reliability.

Better Diagnosis, Better Patient Experience, Better Care